Analyst Ratings for Ionis Pharmaceuticals (ions)
ions Rating Summary
ions Price Target Summary
- Highest: $115.00 (H.C. Wainwright)
- Lowest: $60.00 (BMO Capital)
- Average: $92.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$92.00 (+54%)
* Over Last 12-Mos
Rating Score: 6.1 / 10
Percentile Rank: 65%
Avg. $ Target:
$92.00 (+54%)
* Over Last 12-Mos
Rating Score: 6.1 / 10
Percentile Rank: 65%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/18/2026 | BMO Capital | David Lebowitz | New Coverage | Market Perform (N/A) |
60.00 (N/A) |
58.63 (59.74) |
1.89% | Details |
| 7/16/2026 | Wolfe Research | Andy Chen | Downgrade | Peerperform (Outperform) |
N/A (N/A) |
54.93 (59.74) |
8.76% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
